TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
31076549
DOI
10.1158/1078-0432.ccr-18-4175
PII: 1078-0432.CCR-18-4175
Knihovny.cz E-resources
- MeSH
- CTLA-4 Antigen immunology metabolism MeSH
- B7-H1 Antigen immunology metabolism MeSH
- Hepatitis A Virus Cellular Receptor 2 immunology metabolism MeSH
- CD8-Positive T-Lymphocytes immunology MeSH
- Adult MeSH
- Carcinoma, Ovarian Epithelial immunology metabolism pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Lysosomal Membrane Proteins immunology metabolism MeSH
- Survival Rate MeSH
- Biomarkers, Tumor immunology metabolism MeSH
- Neoplasm Proteins immunology metabolism MeSH
- Prognosis MeSH
- Gene Expression Regulation, Neoplastic * MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Cystadenocarcinoma, Serous immunology metabolism pathology MeSH
- Lymphocytes, Tumor-Infiltrating immunology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
- Names of Substances
- CTLA-4 Antigen MeSH
- B7-H1 Antigen MeSH
- Hepatitis A Virus Cellular Receptor 2 MeSH
- CD274 protein, human MeSH Browser
- CTLA4 protein, human MeSH Browser
- HAVCR2 protein, human MeSH Browser
- LAMP3 protein, human MeSH Browser
- Lysosomal Membrane Proteins MeSH
- Biomarkers, Tumor MeSH
- Neoplasm Proteins MeSH
PURPOSE: In multiple oncological settings, expression of the coinhibitory ligand PD-L1 by malignant cells and tumor infiltration by immune cells expressing coinhibitory receptors such as PD-1, CTLA4, LAG-3, or TIM-3 conveys prognostic or predictive information. Conversely, the impact of these features of the tumor microenvironment on disease outcome among high-grade serous carcinoma (HGSC) patients remains controversial. EXPERIMENTAL DESIGN: We harnessed a retrospective cohort of 80 chemotherapy-naïve HGSC patients to investigate PD-L1 expression and tumor infiltration by CD8+ T cells, CD20+ B cells, DC-LAMP+ dendritic cells as well as by PD-1+, CTLA4+, LAG-3+, and TIM-3+ cells in relation with prognosis and function orientation of the tumor microenvironment. IHC data were complemented with transcriptomic and functional studies on a second prospective cohort of freshly resected HGSC samples. In silico analysis of publicly available RNA expression data from 308 HGSC samples was used as a confirmatory approach. RESULTS: High levels of PD-L1 and high densities of PD-1+ cells in the microenvironment of HGSCs were strongly associated with an immune contexture characterized by a robust TH1 polarization and cytotoxic orientation that enabled superior clinical benefits. Moreover, PD-1+TIM-3+CD8+ T cells presented all features of functional exhaustion and correlated with poor disease outcome. However, although PD-L1 levels and tumor infiltration by TIM-3+ cells improved patient stratification based on the intratumoral abundance of CD8+ T cells, the amount of PD-1+ cells failed to do so. CONCLUSIONS: Our data indicate that PD-L1 and TIM-3 constitute prognostically relevant biomarkers of active and suppressed immune responses against HGSC, respectively.
Department of Dermatology Yale School of Medicine New Haven Connecticut
Department of Radiation Oncology Weill Cornell Medical College New York New York
INSERM U970 Université Paris Descartes Sorbonne Paris Cité Paris France
Sandra and Edward Meyer Cancer Center New York New York
Service d'Immunologie Biologique AP HP Hopital Européen Georges Pompidou Paris France
References provided by Crossref.org
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer